Cite Filings / STOK / 0001123292-24-000282
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
SC 13D/A

Beneficial Ownership Report

Stoke Therapeutics, Inc. · Filed 2024-09-23 · Acc 0001123292-24-000282

Documents 1

  • SC 13D/A Beneficial Ownership Report , stoke13d.htm

Around this filing

  • 2024-09-23 SC 13D/A Beneficial Ownership Report
  • 2024-09-23 4 10% owner sold 1,937,500 shares at $14.05 ($27,221,875)
  • 2024-09-19 144 Sale of Securities
  • 2024-04-18 SC 13D/A Beneficial Ownership Report

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2026-11-16 SCHEDULE 13G/A · RTW Investments, LP 9.9%
  2. 2026-11-16 SCHEDULE 13G/A · Baker Bros. Advisors LP 4.7%
  3. 2026-11-16 SCHEDULE 13G/A · Wellington Management Group LLP 7.3%
  4. 2026-11-13 SCHEDULE 13G/A · Morgan Stanley 4.9%
  5. 2026-08-12 SCHEDULE 13G/A · The Toronto-Dominion Bank 4.9%
  6. 2026-05-15 SCHEDULE 13G/A · The Toronto-Dominion Bank 5.4%
Loading stoke13d.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…